Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of the NeuroSENSE for Monitoring the Hypnotic Depth of Anesthesia

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* age 18-75 years~* ASA (American Society of Anesthesiologist) physical status I, II, or III~* ability to read and understand the informed consent form~* undergoing anesthesia procedure requiring intubation~* scheduled to undergo either open or laparoscopic abdominal surgical procedures (e.g. colectomy, hysterectomy, radical retropubic prostatectomy, nephrectomy, pancreatectomy, etc.), breast surgery including reduction, reconstruction and mastectomies, or orthopedic surgeries under general anesthesia, expected to last at least 1 hour.~Exclusion Criteria:~* history of major head injury (possible abnormal EEG)~* acquired scalp or skull abnormalities (e.g. psoriasis, eczema, angioma, scar tissue, burr holes, cranial implants)~* evidence of recent trauma or active neurological disorder, stroke, seizure disorder, intellectual disability, dementia or diagnosis of Alzheimer's disease~* major antipsychotic medications taken within last 7 days (eg. Lithium, risperidone, olanzapine)~* known history of alcohol or drug abuse within last 30 days~* body mass index (weight in kilograms divided by square of height in meters) \> 40.0 kg/m2~* uncontrolled hypertension with blood pressure recorded prior to surgery (systolic blood pressure \> 200 mmHg or diastolic blood pressure \> 110 mmHg)~* systolic blood pressure \< 90 mmHg, recorded prior to surgery~* heart rate (HR) \< 45 beats/min, recorded prior to surgery~* insulin-dependent diabetes mellitus~* pregnancy~* any serious medical condition that would interfere with cardiovascular response assessment or study results interpretation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Anesthesia (Type: None): A single study group undergoing general anesthesia procedure to observe post-hoc the effect on the NeuroSENSE monitor readings.~Interventions of interest:~Drug: Propofol induction followed by randomized doses of desflurane; Emergence by stepping down the desflurane ET - See intervention descriptions.~Device: Recording of EEG using NeuroSENSE (blinded to clinicians) - See intervention descriptions.~Other: Data Collection - See intervention descriptions

Based on this trial design, predict the completion outcome and termination type (if applicable).